JPMorgan Europe Research Enhanced Index Equity UCITS ETF - EUR (dist) EUR is a equity ETF from JPMorgan tracking the Europe Research Enhanced Index Equity index through physical replication. Domiciled in Ireland and launched in 2021, the fund manages about 120 M € and charges a TER of 0.25% — 25 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
| ASML Holding N.V. | 5.1% |
| AstraZeneca PLC | 2.4% |
| Siemens Aktiengesellschaft | 2.3% |
| Shell plc | 2.2% |
| HSBC Holdings PLC | 2.2% |
| Nestle S.A. | 2.1% |
| Allianz SE VNA O.N. | 2.0% |
| Roche Holding AG | 2.0% |
| Novartis AG | 1.9% |
| Infineon Technologies AG | 1.8% |
| London Stock Exchange | JRDE | GBX |
| London Stock Exchange | JRED | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.